Health Canada drug identification number

DIN 02457717 — MDK-NITISINONE 2 MG

MDK-NITISINONE is a capsule of Nitisinone marketed by MENDELIKABS INC. The full Nitisinone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02457717
Brand name
MDK-NITISINONE
Active ingredient
Nitisinone
Strength
2 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
MENDELIKABS INC
Health Canada status
MARKETED
Drug class
4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitor

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Nitisinone products

DINBrandStrengthFormManufacturerStatus
02457733 MDK-NITISINONE 10 MG CAPSULE MENDELIKABS INC MARKETED
02470055 MDK-NITISINONE 20 MG CAPSULE MENDELIKABS INC DORMANT
02457725 MDK-NITISINONE 5 MG CAPSULE MENDELIKABS INC MARKETED
02459728 ORFADIN 10 MG CAPSULE SWEDISH ORPHAN BIOVITRUM AB (PUBL) MARKETED
02459698 ORFADIN 2 MG CAPSULE SWEDISH ORPHAN BIOVITRUM AB (PUBL) MARKETED
02459736 ORFADIN 20 MG CAPSULE SWEDISH ORPHAN BIOVITRUM AB (PUBL) MARKETED
02469693 ORFADIN 4 MG SUSPENSION SWEDISH ORPHAN BIOVITRUM AB (PUBL) MARKETED
02459701 ORFADIN 5 MG CAPSULE SWEDISH ORPHAN BIOVITRUM AB (PUBL) MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.